Clinical Trial Update: Odiparcil QT Definitive Study [Phase 1]

View source ↗

Summary

The Odiparcil QT Definitive Study (Phase 1) has been terminated. No results are disclosed in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Odiparcil (odiparcil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Fibrillation, Atrial, Atrial Fibrillation | Phase 1 | Status: TERMINATED